Late-Breaking Clinical Trials: Innovations in Ablation & Electrophysiology Technologies

September 20, 2026 | 09:35 AM (EDT) - 10:35 AM (EDT)

Share This event

Speakers
Dhanunjaya R. Lakkireddy
Executive Medical Director of the Kansas City Heart Rhythm Institute
HCA Midwest in Overland Park, Kansas
Devi G Nair, MD, FHRS
Director of the Cardiac Electrophysiology & Research
St. Bernards Medical Center & Arrhythmia Research Group
Douglas Packer
Professor of Medicine
Intermountain Medical Center
Vivek Y. Reddy
Director of Cardiac Arrhythmia Services
Mount Sinai Health System
Moderators
Ravi Ranjan
Section Chief of Cardiac Electrophysiology
University of Utah
Andrea Sarkozy
Professor of Cardiology & Free University of Brussels Director
Ventricular Arrhythmia & Sudden Death Unit, UZ Brussel
Harikrishna Tandri
Professor of Medicine; Chief of Electrophsyiology
Vanderbilt University Medical Center

Late-Breaking Clinical Trials: Innovations in Ablation & Electrophysiology Technologies

Main Stage 2
September 20, 2026 | 09:35 AM (EDT) - 10:35 AM (EDT)

This late-breaking clinical trials session showcases novel therapies and technologies advancing the treatment of atrial and ventricular arrhythmias. Presentations include first-in-human and multicenter clinical data on wearable neuromodulation following pulse field ablation, next-generation pulse field ablation techniques, innovative lesion creation strategies for ventricular tachycardia, map-guided redo ablation for persistent atrial fibrillation, and 4D intracardiac echocardiography to support left atrial appendage closure and concomitant ablation procedures. Together, these studies highlight emerging approaches designed to improve procedural precision, safety, and long-term rhythm outcomes in electrophysiology.